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All known MAP kinase cascades have a simple three
tier linear architecture; yet despite their diverse range
of inputs, they provide exquisitely precise and sensi-
tive responses. Recent studies have shown that dif-
ferential use of pathway components enhances
pathway specificity, facilitates signal integration and
confers output selectivity.
MAP kinases are a family of enzymes that coordinate
diverse cellular programs in response to signals relayed
from the extracellular milieu. They are components of
signalling pathways that have a common architecture,
in which the MAP kinases themselves are the terminal
members of a three-component linear kinase cascade.
The MAP kinases are activated by dual phosphorylation
on a conserved Thr-Xxx-Tyr motif in their activation
loop by an upstream MAP kinase kinase (MAP2K).
MAP2Ks are themselves activated by dual phosphory-
lation by MAP2K kinases (MAP3Ks). Confusingly, these
enzymes have various alternative names, which are
summarised in Table 1.
Three families of MAP kinases have been identified:
the extracellular signal regulated protein kinases, ERK1
and ERK2; the c-Jun NH2 terminal kinases, JNK1,
JNK2 and JNK3; and the p38 MAP kinases, α, β, δ and
γ. A handful of other MAP kinases, including ERK5 and
ERK3, have been discovered that are less well
understood and may have divergent properties [1,2].
Each of the MAP kinase families has at least two
cognate MAP2Ks and multiple MAP3Ks. MAP2Ks
display remarkable substrate specificity for their MAP
kinases; several recognize only one or two MAP
kinases and few if any other substrates. In contrast,
MAP3Ks have the capacity to activate multiple MAP
kinase cascades (Figure 1). The multiple mammalian
MAP3Ks and MAP2Ks may have arisen because mam-
malian MAP kinases must sense a panoply of ligands
and hence have evolved multiple components sensi-
tive to ligand subsets. 
A recent study by Brancho et al. [3], who have inves-
tigated how MAP kinases are activated by diverse
upstream pathway components and the consequences
of these choices, has shed new light on the features of
MAP kinase cascades that provide them their remark-
able response specificity.
Signaling Specificity: Multiple Means to One End
How do these simply organized MAP kinase cascades
respond to ligands that activate different cellular
programs? Several mechanisms have been elucidated
that confer signaling specificity. For example, scaff-
olding proteins have been identified for each MAP
kinase family [4]. These proteins enhance signaling
fidelity by sequestering the kinases and insulating
them from inappropriate activation. An additional layer
of regulation arises from stimulus-selective phospho-
rylation of scaffolds which determines the components
that can bind to them [5]. The presence of distinct sub-
cellular pools of kinases, often created by selective
interaction with scaffolds, limits their access to specific
regulators and substrates [6,7]. 
MAP kinases have specificity-determining motifs to
which bind scaffold proteins, activators and effectors.
They have a docking groove and acidic common
docking (CD) and Glu-Asp (ED) pockets which are
distinct from their active sites [8–10]. Complementing
these MAP kinase motifs, many of the proteins they
interact with — MAP kinase substrates, MAP2Ks, phos-
phatases and scaffolds — have a docking (D) domain,
composed of basic and hydrophobic residues [8,11].
The crystal structures of a p38 MAP kinase bound to
peptides based on the D domains of the p38 activator
MKK3b and a substrate MEF2A show that both D
domains bind to the same docking groove on p38,
although in the opposite orientation [10]. The binding of
the D domain peptides causes distinct conformational
changes in p38, leading to the hypothesis that activa-
tors and effectors use the same site on a MAP kinase to
regulate the enzyme in different ways. Specificity also
comes from the differential use of MAP3Ks and
MAP2Ks, depending on the extracellular cue.
Stimuli Couple to Subsets of Kinase Components
The characterization of several MAP3Ks that have the
capacity to activate MAP kinases from more than one
MAP kinase family has provoked a reconsideration of
cascade architecture. Why are there multiple MAP3Ks
for any given MAP kinase? Some ligands may stimulate
a single MAP3K. Other ligands may activate more than
one MAP3K, causing a more complex response
through parallel activation of pathways and amplifica-
tion of the signal to a pathway accessed by more than
one MAP3K. 
These potential mechanisms were evaluated by
studying the requirement for MAP3Ks in the activation
of the JNK pathway in Drosophila S2 cells [12]. In these
cells, loss of the TGFβ-activated kinase (TAK1), a
MAP3K, completely abrogated JNK activation by
lipopolysaccharide. On the other hand, osmotic stresses
used four MAP3Ks to activate JNK. Lipopolysaccharide
acts predominantly through a single receptor, TLR4,
while osmotic stresses conscript diverse mechanisms
including growth factor receptor transactivation [13].
MAP2Ks May Be Called Up For Overtime Duty
p38s and JNKs are activated by numerous stress
stimuli — p38s by the MAP2Ks MKK3/6 and JNKs by
MKK4/7 [14]. MKK4 can also activate p38 in vitro, but
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the physiological significance has been unclear.
Recently, Brancho et al. [3] re-examined the require-
ments for MKK3, MKK4 and MKK6 in p38 activation
by different stimuli, using gene disruption and RNA
inferference (RNAi) [3]. Their studies revealed that, in
spite of a differential requirement for MKK3 and
MKK6, both were essential for activation of p38 by
TNFα. Intriguingly, they found that fibroblasts lacking
both MKK3 and MKK6 showed residual UV-activation
of p38 which was dependent on MKK4. This provided
the first evidence for a physiological role of MKK4 in
a p38 pathway.
Agents that engender global changes in cell
homeostasis, such as UV and osmotic shock, may do
so by harnessing multiple MAP2Ks and MAP3Ks in dif-
ferent pathways to generate a pleiotropic response.
Consistent with the linkage of MAP2Ks to p38 as a
function of stimulus, Brancho et al. [3] also showed that
ligands which activate p38 use the upstream activators
of p38 differentially to achieve the desired response.
This feature is mirrored in the JNK pathway, where it
has been shown that the JNK activators anisomycin
and heat shock preferentially use MKK4 over MKK7
[15], but proinflammatory cytokines use predominantly
MKK7 [16].
With all the ligands tested, however, maximum acti-
vation required two MAP2Ks: MKK3 and MKK6 for p38,
and MKK4 and MKK7 for JNK. The requirement for
both MAP2Ks has been attributed to the selective
recognition of individual phosphorylation sites by these
MAP2Ks: in vitro MKK4 preferentially catalyzes phos-
phorylation of the activation loop tyrosine, while MKK7
phosphorylates the threonine [16,17]. The fact that
these MAP kinases are still activated in the absence of
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Table 1. Alternative acronyms for components of MAP kinase cascades.
Kinase Acronym Example
MAP kinase kinase kinase MAP3K, MEKK, MKKK MEKK1-4 Ste20 homologs
MAP kinase kinase MAP2K, MKK, MEK MKK3, MEK3, MKK6, MEK6
MAP kinase MAPK ERK1/2, p38α,β,γ,δ, JNK1–3
Figure 1. Building specificity into MAP kinase cascades.
MAP kinase cascades use multiple methods to achieve specific responses to diverse stimuli. These include using scaffolds, the dif-
ferential use of MAP2Ks and MAP3Ks, and the use of proteins such as TAB1 which activates MAP kinases independently of MAP2Ks.
ERK1/2 ERK3p38JNK1-3 ERK5
MEK1/2 ERK3 KMEK3,6MEK4,7
A-Raf, B-Raf, Raf1
MEK5
Response
MEKK1,2,3,4 TPL2 MLK3 TAO1,2,3 ASK1,2 TAK1,2,3
MAPK
Scaffold
TAK1
MEK4,7
JNK
MAP3K
TAK1 MLK2 ASK1 MEKK1
JNK
MEK4 MEK7
SorbitolLPS
p38
p38
TAB1
MEK3,6
MAP3K
MAP2K
Current Biology
individual MAP2Ks suggests, either that each MAP2K
can catalyze both phosphorylations, or that autophos-
phorylation contributes to activation. MAP kinase
autophosphorylation can occur on activation loop sites.
MAP2K-Independent Activation of MAP Kinases
The predominant mode of MAP kinase activation is by
dual phosphorylation by MAP2Ks on the activation
loop sites. Nevertheless, MAP2K-independent activa-
tion has been reported for p38 via the TAK1 binding
protein TAB1 [18]. TAB1 enhances p38 autophospho-
rylation in a stimulus-specific manner in the absence of
MKK3 and MKK6. Activation of p38 by ischemia as a
consequence of myocardial injury, for example, report-
edly occurs by TAB1-induced p38 autophosphoryla-
tion [19]. Scaffolds may more generally take an active
part in kinase activation than previously recognized.
The motor-binding protein TPX2 has been shown to
promote activation of the Aurora A kinase by promot-
ing its autophosphorylation [20].
In conclusion, these studies provide insight into the
myriad mechanisms that create specificity from the
three kinase module. Signals initiated by diverse extra-
cellular ligands induce ligand-specific re-wiring of
kinase components via scaffolding proteins and distinct
binding motifs to produce signal-specific, custom-
made signal transduction cascades. 
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